Inventor · disambiguated record
James Keck
Also filed as: KECK JAMES · KECK JAMES G
8 granted patents·10 pending applications·36 citations·filing 1999–2024
82Inventor score
Top patents by PatentIndex Score
18 records- 0190US11959926B2Method of determining toxicity of an immunomodulatory drug for use in humans preliminary classJACKSON LAB·Filed 2023·Granted Apr 16, 2024·2 cites·20 claims
- 0283US11248236B2Non-HLA matched humanized NSG mouse model with patient-derived xenograftJACKSON LAB·Filed 2017·Granted Feb 15, 2022·2 cites·10 claims
- 0382US12196744B2Humanized mouse models for assessing immune cell therapyJACKSON LAB·Filed 2022·Granted Jan 14, 2025·1 cites·11 claims
- 0482US11959925B2Method of determining toxicity of an immunomodulatory drug for use in humansJACKSON LAB·Filed 2018·Granted Apr 16, 2024·2 cites·15 claims
- 0581US12409237B1Methods and models for assessing efficacy of immunotherapiesJACKSON LAB·Filed 2024·Granted Sep 9, 2025·0 cites·10 claims
- 0679US12510548B2Method of determining toxicity of an immunomodulatory drug for use in humansJACKSON LAB·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 0771US6803194B1Use of ribozymes for functionating genesHK PHARMACEUTICALS INC·Filed 1999·Granted Oct 12, 2004·28 cites·11 claims
- 0869US2025164467A1Humanized mouse models for assessing immune cell therapyJACKSON LAB·Filed 2024·Application pending·0 cites
- 0966US8207121B2Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compoundBROWN GAIL L·Filed 2007·Granted Jun 26, 2012·1 cites·2 claims
- 1064US2008159980A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2007·Application pending·0 cites
- 1161US2025057128A1Humanized mouse modelsJACKSON LAB·Filed 2022·Application pending·0 cites
- 1259US2019320633A1Humanized mouse model with improved human innate immune cell developmentJACKSON LAB·Filed 2017·Application pending·0 cites
- 1359US2025369955A1Mouse models of cytokine release syndromeJACKSON LAB·Filed 2023·Application pending·0 cites
- 1457US2004138140A1Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapyTELIK INC·Filed 2003·Application pending·0 cites
- 1557US2025311707A1Transgenic mouse models of human adaptive and innate immunity and methods of useJACKSON LAB·Filed 2023·Application pending·0 cites
- 1652US2003087288A1Use of ribozymes for functionating genesFiled 2002·Application pending·0 cites
- 1752US2005261202A1Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compoundBROWN GAIL L·Filed 2005·Application pending·0 cites
- 1851US2024041011A1Infectious disease mouse modelsJACKSON LAB·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Keck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →